Stockreport

Citi Raises Gilead (GILD) Price Target Ahead of Q1 Biopharma Preview [Yahoo! Finance]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF On April 13, Citi analyst Geoff Meacham lifted the firm's price recommendation on Gilead Sciences, Inc. (NASDAQ:GILD) to $165 from $156. It reiterated a Buy rating on t [Read more]